BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26400440)

  • 1. Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody.
    Xue L; Hickling T; Song R; Nowak J; Rup B
    Clin Exp Immunol; 2016 Jan; 183(1):102-13. PubMed ID: 26400440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.
    Karle A; Spindeldreher S; Kolbinger F
    MAbs; 2016; 8(3):536-50. PubMed ID: 26817498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.
    Zou GM; Martinson J; Hu WY; Tam Y; Klingemann HG
    Cancer Immunol Immunother; 2004 Aug; 53(8):681-9. PubMed ID: 15103504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
    Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response.
    Osada T; Nagawa H; Takahashi T; Tsuno NH; Kitayama J; Shibata Y
    J Immunother; 2002; 25(2):176-84. PubMed ID: 12074047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
    Todate A; Suda T; Kuwata H; Chida K; Nakamura H
    J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
    Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
    J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells.
    Wadia PP; Herrera ND; Abecassis MM; Tambur AR
    Hum Immunol; 2009 Sep; 70(9):692-700. PubMed ID: 19445989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
    Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
    J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model.
    Hunter TB; Alsarraj M; Gladue RP; Bedian V; Antonia SJ
    Scand J Immunol; 2007 May; 65(5):479-86. PubMed ID: 17444959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerance by IL-10-treated dendritic cells.
    Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
    J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
    McLellan AD; Sorg RV; Williams LA; Hart DN
    Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of interleukin-10 differentiated dendritic cell of allergic asthma patients in T-lymphocyte proliferation in vitro].
    Tang JF; Guan SH; Wang ZG
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2851-4. PubMed ID: 23290216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).
    Ghoneum M; Agrawal S
    Int J Immunopathol Pharmacol; 2011; 24(4):941-8. PubMed ID: 22230400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human dendritic cells by porcine aortic endothelial cells: transactivation of naïve T cells through costimulation and cytokine generation.
    Manna PP; Duffy B; Olack B; Lowell J; Mohanakumar T
    Transplantation; 2001 Nov; 72(9):1563-71. PubMed ID: 11707746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.